# A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

> **NCT00834457** · PHASE2,PHASE3 · COMPLETED · sponsor: **Parirenyatwa Hospital** · enrollment: 49 (actual)

## Conditions studied

- AIDS-related Kaposi's Sarcoma

## Interventions

- **DRUG:** abacavir/3TC/zidovudine
- **DRUG:** abacavir /3TC plus ritonavir boosted lopinavir

## Key facts

- **NCT ID:** NCT00834457
- **Lead sponsor:** Parirenyatwa Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2014-10-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00834457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00834457, "A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00834457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*